EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study

Arkadeep Dhali iD, Jyotirmoy Biswas, Fayaz Khan, Dushyant Singh Dahiya, Saikat Mandal iD

Journal of Personalized Medicine · 20.08.2026 · 16 (8) · 437

DOI: 10.3390/jpm16080437 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Personalized Medicine, online erschienen am 20.08.2026. Verfasst von Arkadeep Dhali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

GLP-1 receptor agonists (GLP-1 RAs) are increasingly used for obesity and metabolic disease, but their use in people with chronic pancreatitis is not a chronic pancreatitis-directed indication and direct evidence is limited. We described recorded outcomes among non-diabetic adults carrying a chronic pancreatitis diagnosis who did or did not have recorded GLP-1 RA exposure.

Methods

We performed a retrospective propensity score-matched cohort study using the TriNetX Collaborative Network. Chronic pancreatitis was identified from a recorded diagnosis; supporting imaging, histological, functional, or specialist-confirmation criteria were unavailable. The exposed cohort included patients receiving dulaglutide, semaglutide, or tirzepatide (n = 1441 before matching), and the comparator cohort included patients without recorded GLP-1 RA exposure (n = 142,047 before matching). One-to-one propensity score matching generated 1422 patients in each cohort. Outcomes were assessed from 1 to 1095 days after the index date using risk comparisons and time-to-event analyses.

Results

Mean follow-up after matching was 458.8 days in the exposed cohort and 664.4 days in the comparator cohort. Recurrent acute pancreatitis was recorded in 19/799 (2.4%) versus 76/704 (10.8%) patients (HR 0.247, 95% CI 0.149–0.409), pancreatic cancer in 10/1373 (0.7%) versus 40/1345 (3.0%) (HR 0.255, 95% CI 0.128–0.511), and all-cause mortality in 21/1419 (1.5%) versus 157/1416 (11.1%) (HR 0.167, 95% CI 0.105–0.263). A similar direction was observed across several coded outcomes. Vitamin D deficiency showed a higher hazard (HR 1.556, 95% CI 1.129–2.145), although its risk comparison was not significant.

Conclusions

These estimates describe outcomes in a selected treatment-exposed phenotype of chronic pancreatitis. The findings are hypothesis-generating and should not guide prescribing decisions. Further prospective studies are required to confirm this hypothesis.

Schlagwörter

Stichwörter der Autor:innen

GLP-1 analoguechronic pancreatitiscohortpancreatic safetypharmacoepidemiology

Autor:innen und Institutionen

  • Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK.
  • School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast BT9 7BL, UK.
  • Department of Medicine, Barasat Government Medical College and Hospital, Barasat 700124, India.
  • Department of Palliative Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Division of Gastroenterology, Hepatology & Motility, School of Medicine, The University of Kansas, Kansas City, KS 66160, USA.
  • School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.

ORCID-Profile: Arkadeep Dhali, Saikat Mandal

Zitieren

APA

Dhali, A., Biswas, J., Khan, F., Dahiya, D. S., & Mandal, S. (2026). Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study. Journal of Personalized Medicine, 16(8), 437. https://doi.org/10.3390/jpm16080437

Vancouver

Dhali A, Biswas J, Khan F, Dahiya DS, Mandal S. Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study. Journal of Personalized Medicine. 2026;16(8):437. doi:10.3390/jpm16080437

BibTeX
@article{Dhali2026,
  author = {Dhali, Arkadeep and Biswas, Jyotirmoy and Khan, Fayaz and Dahiya, Dushyant Singh and Mandal, Saikat},
  title = {Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {437},
  doi = {10.3390/jpm16080437}
}
Kostenlos starten →